Prson Gautam

10PUBLICATIONS

88CO-AUTHORS

Molecular targetsCancer diagnosisCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Oct 08, 2026

Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer.

|Jun 06, 2024

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.

Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker

|Dec 18, 2021

Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.

Clint A Stalnecker, Kajal R Grover, A Cole Edwards

|Jun 19, 2021

CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.

Anni Laine, Srikar G Nagelli, Caroline Farrington

|Feb 20, 2021

Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.

Aleksandr Ianevski, Jenni Lahtela, Komal K Javarappa

|Dec 28, 2020

Multiobjective optimization identifies cancer-selective combination therapies.

Otto I Pulkkinen, Prson Gautam, Ville Mustonen

Pageof 2

Frequent Collaborators

Krister Wennerberg

Tero Aittokallio

Kirsten L Bryant

Craig M Goodwin

Björn Papke

Adrienne D Cox

Clint A Stalnecker

Channing J Der

Andrew M Waters

Jeffrey A Klomp

Frequent Collaborators

Krister Wennerberg

Tero Aittokallio

Kirsten L Bryant

Craig M Goodwin